Has Zachary Soler, MD received payments from drug or device companies?

Yes. Drug and device makers reported $66,864 in general payments to Zachary Soler, MD across 68 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Zachary Soler, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Zachary Soler, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Zachary Soler, MD

Otolaryngology · Charleston, SCNPI 1619121464

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.6%), speaking fees and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Optinose US, Inc. at 26.5% of the total. Reporting peaked in 2021 at $15,449 and has fallen 63.1% since, to $5,698 in 2025. Among otolaryngology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,864in general payments, 2019–2025

Across 68 payments — averaging $983.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Optinose US, Inc.$18K
Olympus Corporation Of The Americas$11K
Sanofi$11K
GSK$10K
Regeneron$10K
Sanofi-aventis U.S. LLC$4K
plus $3K from 2 others

$770,707in research payments, 2019–2025

Across 10 payments — averaging $77,071 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$768K
Novartis$2K

What the payments were for

Consulting fees$39,84560%
Speaking & faculty fees$14,60422%
Travel & lodging$7761%
Food & beverage$1,4392%
Education$10,20015%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Optinose US, Inc.	25	$17,731
Olympus Corporation Of The Americas	15	$11,200
Sanofi	18	$10,500
GSK	1	$10,400
Regeneron	5	$10,140
Sanofi-aventis U.S. LLC	1	$4,104
Genentech, Inc.	1	$2,680
Stryker	2	$109

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,864 in reported general payments places this provider in the 95th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$165,606

Medicare patients

363

Services billed

1,297

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	33	$158,118
Dupixent SyringeDupilumab	16	$78,302
Ipratropium Bromide	71	$2,773
Azelastine-FluticasoneAzelastine/Fluticasone	17	$2,534
Mometasone Furoate	17	$2,088
Azelastine Hcl	37	$772
Fluticasone Propionate	33	$510
Doxycycline Hyclate	20	$290
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	17	$150
Prednisone	13	$22
Easy Touch Alcohol Prep PadsAlcohol Antiseptic Pads	13	$13

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Charleston

Shaun NguyenCharleston$973K
Rodney SchlosserCharleston$382K
Eugene BrownCharleston$28K
Jason NewmanCharleston$26K
Joshua HornigCharleston$25K
Ashli OrourkeCharleston$21K
Alexandra KejnerCharleston$19K
Evan GraboyesCharleston$18K
Mohamed AbdelwahabCharleston$15K
Jeffrey HoultonCharleston$11K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →